Trial Profile
Randomized Controlled Trial of Early Conversion from Calcineurin Inhibitor to Everolimus in Adult Renal Allograft Patients at a Single Transplant Center in Mexico
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Jul 2012
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Basiliximab; Prednisone; Tacrolimus
- Indications Renal transplant rejection
- Focus Adverse reactions
- 25 Jul 2012 New trial record